Investor Relations

Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).

Share price

Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD

Latest CEO Comments

JULY 15, 2021

"First commercial DTx contract signed
with a large healthcare provider"

Read the latest CEO comments from Nikolaj Sørensen

Key financial figures

Group net revenue

585 MSEK
Last Twelve Months, Q320-Q221

Group EBITDA

-76 MSEK
Last Twelve Months, Q320-Q221

US Pharma segment EBIT

295 MSEK
Last Twelve Months, Q320-Q221

Cash position

680 MSEK
Q221
IR-Contact